Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely (NYSE:NVS)
· seekingalpha.com
Antares-Novartis AG oncology partnership: $105M upfront, up to $1.8B milestones, and what it signals for NVS amid patent cliffs. Click for this look at the deal.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...